How Recent Shifts Are Reframing The Biocon (NSEI:BIOCON) Investment Narrative [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class B (BIO.B)
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
Biocon's fair value estimate has been adjusted slightly, moving from ?421.60 to ?420.74, a change of less than 1% that keeps the price target broadly in line with earlier expectations. Analysts largely view this as fine tuning of their models rather than a major reset, with debate centering on what could support upside and what might limit near term returns. Read on to see how to interpret this update and what to watch as the Biocon story continues to evolve. Stay updated as the Fair Value for Biocon shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Biocon. What Wall Street Has Been Saying ?? Bullish Takeaways Street research on comparable life sciences names such as Bio Rad highlights that even when near term results fall short of expectations, some analysts still see potential value in underlying portfolios. This can support more constructive views on companies like Biocon, where assets and pipelines ar
Show less
Read more
Impact Snapshot
Event Time:
BIO.B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO.B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO.B alerts
High impacting Bio-Rad Laboratories, Inc. Class B news events
Weekly update
A roundup of the hottest topics
BIO.B
News
- Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026 [Yahoo! Finance]Yahoo! Finance
- Artisan Mid Cap Value Fund Sold Bio-Rad Laboratories (BIO) in Q4 [Yahoo! Finance]Yahoo! Finance
- Global Ion Exchange Materials Market to Reach $5.9 Billion by 2030, Driven by Green Hydrogen, Water Treatment Standards and Energy Security Demands [Yahoo! Finance]Yahoo! Finance
- Greeley's Cascadia hockey stadium project tentatively blocked by voters, some say "a gut punch" for Northern Colorado [CBS News]CBS News
- ????????????:2024???2032????286??????374????????????3%??? [CNET News]CNET News